Missouri drugmaker latest to recall metformin over carcinogen

Maia Anderson –
Wednesday, November 4th, 2020
Print|Email.

More articles on pharmacy: Mylan, Pfizer get federal OK for merger with UpjohnNovartis includes brand-new limitation to 340B discount rate policyVirginia pharmacist gets 2 years in prison for prescription drug scheme.

Nostrum recalled four lots of its metformin tablets after discovering levels of N-Nitrosodimethylamine, or NDMA, above the FDAs appropriate day-to-day consumption level. Metformin is meant to improve blood glucose control in grownups with Type 2 diabetes..

Nostrum signs up with the list of over a lots drugmakers who have remembered their metformin products considering that the FDA first revealed in May that it had actually found unacceptable levels of NDMA in metformin. The pollutant was originally found by online drug store Valisure in early March..

A Kansas City, Mo.-based drugmaker, Nostrum Laboratories, has become the current business to remember its diabetes drug, metformin, after finding it includes unacceptably high levels of a carcinogen..

Nostrum said its metformin pills were distributed across the country to wholesalers, and it hasnt gotten any negative occasion reports connected to the drug..

The drugmaker also warned that it might be unsafe for clients with Type 2 diabetes to stop taking their metformin prior to talking to a health care company..

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.